Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Sun, Dongdong ^a   Huang, Jie ^a   Zhang, Zheng ^a   Gao, Haokao ^a   Li, Jiayi ^a   Shen, Min ^a   Cao, Feng ^a   Wang, Haichang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; LUTEOLIN; MYELOPEROXIDASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; WORTMANNIN; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CORONARY ARTERY LIGATION; DISEASE SEVERITY; DRUG ANTAGONISM; ENZYME ACTIVATION; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; INCIDENCE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REPERFUSION INJURY; STREPTOZOCIN DIABETES; UPREGULATION; ANIMAL; CELL MOTION; DRUG EFFECT; ECHOGRAPHY; EXPERIMENTAL DIABETES MELLITUS; HEART FUNCTION TEST; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; LEUKOCYTE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; APOPTOSIS; ARRHYTHMIAS, CARDIAC; CELL MOVEMENT; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; HEART FUNCTION TESTS; L-LACTATE DEHYDROGENASE; LEUKOCYTES; LUTEOLIN; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FUNCTION, LEFT;

EID: 84863252874     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033491     Document Type: Article

References (32)

1. Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, et al. (2007) Diabetes and mortality following acute coronary syndromes. Jama 298: 765-775.
2. (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421.
3. Cao F, Sun D, Li C, Narsinh K, Zhao L, et al. (2009) Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. Eur Heart J 30: 1986-1994.
4. Liang JL, Xiao DZ, Liu XY, Lin QX, Shan ZX, et al. (2010) High glucose induces apoptosis in AC16 human cardiomyocytes via macrophage migration inhibitory factor and c-Jun N-terminal kinase. Clin Exp Pharmacol Physiol 37: 969-973.
5. Wu Y, Xia ZY, Dou J, Zhang L, Xu JJ, et al. (2011) Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Mol Biol Rep 38: 4327-4335.
6. Younce CW, Wang K, Kolattukudy PE, (2010) Hyperglycaemia-induced cardiomyocyte death is mediated via MCP-1 production and induction of a novel zinc-finger protein MCPIP. Cardiovasc Res 87: 665-674.
7. Yu XY, Geng YJ, Liang JL, Lin QX, Lin SG, et al. (2010) High levels of glucose induce apoptosis in cardiomyocyte via epigenetic regulation of the insulin-like growth factor receptor. Exp Cell Res 316: 2903-2909.
8. Song JQ, Teng X, Cai Y, Tang CS, Qi YF, (2009) Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion. Apoptosis 14: 1299-1307.
9. Matsunaga S, Okigaki M, Takeda M, Matsui A, Honsho S, et al. (2009) Endothelium-targeted overexpression of constitutively active FGF receptor induces cardioprotection in mice myocardial infarction. J Mol Cell Cardiol 46: 663-673.
10. Negoro S, Oh H, Tone E, Kunisada K, Fujio Y, et al. (2001) Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Circulation 103: 555-561.
11. Zou Y, Takano H, Mizukami M, Akazawa H, Qin Y, et al. (2003) Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction. Circulation 108: 748-753.
12. Shiraishi I, Melendez J, Ahn Y, Skavdahl M, Murphy E, et al. (2004) Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res 94: 884-891.
13. Li L, Henry GE, Seeram NP, (2009) Identification and bioactivities of resveratrol oligomers and flavonoids from Carex folliculata seeds. J Agric Food Chem 57: 7282-7287.
14. Lopez-Lazaro M, (2009) Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem 9: 31-59.
15. Park YJ, Kim HJ, Lee SJ, Choi HY, Jin C, et al. (2007) A new chromone, 11-hydroxy-sec-O-glucosylhamaudol from Ostericum koreanum. Chem Pharm Bull (Tokyo) 55: 1065-1066.
16. Seelinger G, Merfort I, Schempp CM, (2008) Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med 74: 1667-1677.
17. Qi L, Pan H, Li D, Fang F, Chen D, et al. (2011) Luteolin improves contractile function and attenuates apoptosis following ischemia-reperfusion in adult rat cardiomyocytes. Eur J Pharmacol 668: 201-207.
18. Rump AF, Schussler M, Acar D, Cordes A, Theisohn M, et al. (1994) Functional and antiischemic effects of luteolin-7-glucoside in isolated rabbit hearts. Gen Pharmacol 25: 1137-1142.
19. Sun D, Shen M, Li J, Li W, Zhang Y, et al. (2011) Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3beta dependent pathway in experimental diabetic cardiomyopathy. Cardiovasc Diabetol 10: 4.
20. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, et al. (1988) The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 22: 447-455.
21. Lancel S, Joulin O, Favory R, Goossens JF, Kluza J, et al. (2005) Ventricular myocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction. Circulation 111: 2596-2604.
22. Lee WL, Cheung AM, Cape D, Zinman B, (2000) Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 23: 962-968.
23. Liao PH, Hung LM, Chen YH, Kuan YH, Zhang FB, et al. (2011) Cardioprotective effects of luteolin during ischemia-reperfusion injury in rats. Circ J 75: 443-450.
24. Middleton E Jr, Kandaswami C, Theoharides TC, (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751.
25. Rump AF, Schussler M, Acar D, Cordes A, Ratke R, et al. (1995) Effects of different inotropes with antioxidant properties on acute regional myocardial ischemia in isolated rabbit hearts. Gen Pharmacol 26: 603-611.
26. Fang F, Li D, Pan H, Chen D, Qi L, et al. (2011) Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through the PI3K/Akt pathway in simulated ischemia/reperfusion. Pharmacology 88: 149-158.
27. Fu J, Huang H, Liu J, Pi R, Chen J, et al. (2007) Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol 568: 213-221.
28. Wang X, Zhang X, Ren XP, Chen J, Liu H, et al. (2010) MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 122: 1308-1318.
29. Chae IH, Park KW, Kim HS, Oh BH, (2004) Nitric oxide-induced apoptosis is mediated by Bax/Bcl-2 gene expression, transition of cytochrome c, and activation of caspase-3 in rat vascular smooth muscle cells. Clin Chim Acta 341: 83-91.
30. Dong JW, Zhu HF, Zhu WZ, Ding HL, Ma TM, et al. (2003) Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression. Cell Res 13: 385-391.
31. Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, et al. (2000) The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 35: 537-544.
32. Xagorari A, Papapetropoulos A, Mauromatis A, Economou M, Fotsis T, et al. (2001) Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther 296: 181-187.